SCHEMBL4154041

SCHEMBL4154041

CN(C(=O)NC1CC1)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.39
PKM P14618 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
TAS1R2 Q8TE23 1/20 0.36
UBE2M P61081 1/20 0.36
DCUN1D1 Q96GG9 1/20 0.36
PDK2 Q15119 4/20 0.35
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
PDE2A O00408 1/20 0.34
DRD2 P14416 1/20 0.33
MCHR1 Q99705 1/20 0.33
NPY5R Q15761 1/20 0.33
MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4149562 0.94 PKM (0.47) EPHX2PKMLMNAMAPTMAPK1
SCHEMBL4145149 0.92 TACR2 (0.36) EPHX2PKMUBE2MDCUN1D1PDK2
SCHEMBL4149723 0.83 TSHR (0.38) EPHX2PDK2LMNAMAPTTSHR
SCHEMBL4141923 0.82 PTGIR (0.36) PDK2DRD2MAPK14
SCHEMBL4142460 0.82 LMNA (0.35) EPHX2PDK2LMNAMAPTTSHR
SCHEMBL13774545 0.81 PKM (0.50) EPHX2PKMLMNAMAPT
SCHEMBL4142022 0.80 PTPRZ1 (0.37) EPHX2PDK2LMNAMAPTTSHR
SCHEMBL4158539 0.80 MAPT (0.36) EPHX2LMNAMAPTTSHRMAPK1
SCHEMBL4149964 0.80 HDAC6 (0.40)
SCHEMBL13774570 0.80 HDAC4 (0.36) EPHX2PKMTAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 EPHX2 2013/4885PKM 3145/4885TAS1R3 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.